company background image
688677 logo

Qingdao NovelBeam TechnologyLtd SHSE:688677 Stock Report

Last Price

CN¥55.60

Market Cap

CN¥6.9b

7D

-1.7%

1Y

-21.3%

Updated

27 Mar, 2024

Data

Company Financials +

Qingdao NovelBeam Technology Co.,Ltd.

SHSE:688677 Stock Report

Market Cap: CN¥6.9b

688677 Stock Overview

Qingdao NovelBeam Technology Co., Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide.

688677 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth5/6
Past Performance2/6
Financial Health6/6
Dividends3/6

Qingdao NovelBeam Technology Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Qingdao NovelBeam TechnologyLtd
Historical stock prices
Current Share PriceCN¥55.60
52 Week HighCN¥78.17
52 Week LowCN¥43.51
Beta-0.81
1 Month Change3.83%
3 Month Change6.60%
1 Year Change-21.29%
3 Year Change3.40%
5 Year Changen/a
Change since IPO38.46%

Recent News & Updates

Recent updates

Shareholder Returns

688677CN Medical EquipmentCN Market
7D-1.7%-4.1%-2.2%
1Y-21.3%-17.1%-14.8%

Return vs Industry: 688677 underperformed the CN Medical Equipment industry which returned -17.1% over the past year.

Return vs Market: 688677 underperformed the CN Market which returned -14.8% over the past year.

Price Volatility

Is 688677's price volatile compared to industry and market?
688677 volatility
688677 Average Weekly Movement7.2%
Medical Equipment Industry Average Movement7.7%
Market Average Movement8.1%
10% most volatile stocks in CN Market11.4%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 688677 has not had significant price volatility in the past 3 months.

Volatility Over Time: 688677's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2003803Yao Zhenghttps://www.novelbeam.com

Qingdao NovelBeam Technology Co., Ltd. engages in the research, development, production, and sales of medical endoscopic instruments and optical products worldwide. The company offers medical device products and components, such as endoscopes, light sources, and camera systems for surgical operations, as well as surgical external vision system, endoscope system, and other complete systems; and optical devices and components, including dental endoscopes, light source modules for microscopes and PCR analysis, fluorescence filters, beauty machine filters, light sheets, and high-energy laser scanning mirror, etc. It also provides optical imaging solutions for clinical medicine; and identity information management solutions based on biometrics. The company was founded in 2003 and is headquartered in Qingdao, China.

Qingdao NovelBeam Technology Co.,Ltd. Fundamentals Summary

How do Qingdao NovelBeam TechnologyLtd's earnings and revenue compare to its market cap?
688677 fundamental statistics
Market capCN¥6.91b
Earnings (TTM)CN¥145.93m
Revenue (TTM)CN¥470.60m

46.3x

P/E Ratio

14.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688677 income statement (TTM)
RevenueCN¥470.60m
Cost of RevenueCN¥0
Gross ProfitCN¥470.60m
Other ExpensesCN¥324.66m
EarningsCN¥145.93m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 25, 2024

Earnings per share (EPS)1.20
Gross Margin100.00%
Net Profit Margin31.01%
Debt/Equity Ratio1.1%

How did 688677 perform over the long term?

See historical performance and comparison

Dividends

1.0%

Current Dividend Yield

43%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.